Methods for embolic protection during treatment of a stenotic lesion in a body vessel

ABSTRACT

A method for embolic protection during treatment of a stenotic lesion in a body vessel is provided. The method comprises disposing an embolic protection device in an undeployed state in the body vessel. The device comprises a basket with a set of struts extending from a distal end to a proximal end of the basket, the struts being arranged to define an opening at the distal end, the basket having an expanded state and a collapsed state. A core wire with a distal end and a proximal end is able to reciprocate through the opening at the distal end of the basket. A filter bag is attached only at the distal end of the core wire, the filter bag being located distally to the distal end of the basket when in the collapsed state. The method further comprises moving the core wire relative to the basket to expand the basket and the filter bag in a deployed state downstream from the stenotic lesion to capture emboli during treatment of the stenotic lesion.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 11/484,425, filed Jul. 11, 2006 now U.S. Pat. No. 7,771,452, entitled “EMBOLIC PROTECTION DEVICE WITH A FILTER BAG THAT DISENGAGES FROM A BASKET,” which claims the benefit of U.S. Provisional Patent Application Ser. No. 60/698,410, filed Jul. 12, 2005, the entire contents of which are incorporated herein by reference.

BACKGROUND

The present invention relates to medical devices. More particularly, the present invention relates to embolic protection devices and methods for capturing emboli within a body vessel.

Presently, there are a number of treatments for embolic protection to prevent emboli and blood clots from traveling within the vasculature that create undesirable medical conditions, such as ischemic stroke, brain aneurysm, and pulmonary embolism. For example, vena cava filters are commonly employed to trap blood clots and emboli in the vena cava filter to prevent pulmonary embolism; snares and baskets (for example, stone retrieval baskets) are generally employed to retrieve urinary calculi; and occlusion coils are typically employed to occlude aneurysms and accumulate thrombi in a body vessel.

Treatments for stenotic lesions create a potential in releasing blood clots and other thrombi plaque in the vasculature of the patient, for example, in the treatment for carotid artery stenosis. Generally, carotid artery stenosis (also called carotid artery disease) is the narrowing of the carotid arteries, which are the main arteries in the neck that supply blood to the brain, usually caused by plaque build-up in the carotid artery, creating a relatively high risk factor for ischemic stroke. Plaque forms when cholesterol, fat and other substances form in the inner lining of an artery. This formation process is known as atherosclerosis.

Depending on the degree of stenosis and the patient's overall condition, carotid artery stenosis has been treated with surgery. This procedure, known as carotid endarterectomy, removes the plaque from the arterial walls. Carotid endarterectomy has been shown to benefit patients with arteries that are substantially narrowed, for example, by about 70% or more. For people with arteries that are not as narrowed, for example, less than about 50%, an anti-clotting drug, such as anti-platelet agents and anticoagulants, may be prescribed to reduce the risk of ischemic stroke.

Carotid angioplasty is a more recently developed treatment for carotid artery stenosis. This treatment uses balloons with or without stents to open a narrowed artery. This procedure can be performed through a standard percutaneous transfemoral approach with the patient anesthetized using light intravenous sedation. At the stenosis area, an angioplasty balloon is delivered to predilate the stenosis in preparation for placement of a stent. The balloon is then removed and exchanged through a catheter for a stent delivery device. Once in position, a stent is deployed across the stenotic area. If needed, another balloon can be placed inside the deployed stent for post-dilation to ensure that the struts of the stent are pressed firmly against the inner surface of the vessel wall.

During the stenosis procedure, there is a risk of blood clots and thrombi being undesirably released into the blood flow within the vasculature. Embolic or distal protection devices have been implemented to capture emboli. However, many current embolic protection devices restrict flow when deployed within the vasculature of the patient. Moreover, many embolic protection devices are relatively difficult to collapse and retrieve after the need for such a device in the vasculature passes.

In view of the above, it is apparent that there exists a need for an improved device and method for distally protecting and capturing emboli within a body lumen during a stenosis procedure.

SUMMARY

The present invention generally provides an embolic protection device that minimizes restricted flow when deployed within the vasculature of a patient and that is relatively easy to retrieve after the risk of releasing blood clots and thrombi within the vasculature has passed. In a general aspect, the embolic protection device includes a basket defined by a section of a set of wires arranged as a plurality of struts. These struts are coupled together at the distal end of the basket in a manner to define an opening at the distal end through which a core wire can reciprocate. Another section of the wires spirals around the core wire to define a hollow channel in which the core wire can reciprocate. A filter bag is attached to the distal end of the core wire such that pulling a proximal end of the core wire relative to the spiraled section engages the filter bag with the distal end of the basket to expand the basket and filter bag for capturing emboli, and pushing the core wire disengages the filter bag from the distal end of the basket to collapse the basket and filter bag.

Hence, the filter bag, basket, and deployment mechanism are all one integral unit with a small cross sectional profile when the device is in a collapsed configuration. Accordingly, during delivery of the device, the small profile enables crossing a lesion without inadvertently dislodging material from the lesion site.

Further features and advantages will be apparent from the following description, and from the claims.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is an environmental view of an embolic protection device in accordance with one embodiment of the present invention;

FIG. 2 is a perspective view of the emboli protection device of FIG. 1;

FIG. 3 is an end view of the embolic protection device along the line 3-3 of FIG. 2;

FIG. 4 a is a side view of the embolic protection device in a collapsed configuration in accordance with one embodiment of the present invention;

FIG. 4 b is a side view of the embolic protection device in a partially expanded configuration in accordance with one embodiment of the present invention;

FIG. 5 a is a side view of an embolic protection assembly for capturing emboli during treatment of a stenotic lesion in accordance with one embodiment of the present invention;

FIG. 5 b is an exploded side view of the assembly in FIG. 5 a;

FIG. 6 is a flow chart of a sequence of steps deploying an embolic protection for treatment of a stenotic lesion in a body vessel; and

FIG. 7 is a flow chart of a sequence of steps for retrieving an embolic protection device for post-treatment of a stenotic lesion in a body vessel.

DETAILED DESCRIPTION

Referring now to FIG. 1, an embolic protection device embodying the principles of the present invention is illustrated therein and designated at 10. The device 10 captures emboli during treatment of a stenotic lesion in a body vessel 11 in accordance with one embodiment of the present invention. As shown in FIGS. 1 and 2, the device 10 includes a basket 14 and a filter portion or bag 22 for capturing emboli in the body vessel 11. The basket 12 is defined by a section of a set of wires arranged as struts 14 that extend longitudinally from a proximal end 16 of the basket 12 to a distal end 18. The plurality of struts 14 are joined together in such a way, for example, by solder, to define an opening through which a core wire 20 can reciprocate. The filter bag 22 is attached to a distal end 24 of the core wire 20 by solder or any other suitable attachment mechanism.

Another section of the set of wires is twisted or spiraled to define a spiraled section 26 with a hollow channel 28 through which the core wire 20 extends along a longitudinal axis A beyond a proximal end 32 of the spiraled portion 26. The filter bag 16 is with the opening of the bag facing the stenotic lesion. Accordingly, clots or emboli flow into the bag when the device 10 is deployed in the vasculature. When in the expanded or deployed configuration, the struts 14 extend longitudinally and curve outwardly between the proximal end 16 of the basket 12 and the distal end 18.

Since the core wire 20 is attached only to the filter bag 22 at the distal end 24 of the core wire, the core wire 20 is able to reciprocate within the hollow channel 28 and through the opening at the distal end 18 of the basket 12. Thus, as shown in FIGS. 4 a and 4 b, grasping the proximal end of the core wire 20 and pulling it relative to the proximal end 32 of the spiraled section 26, pulls the filter bag 22 over the basket 12. Once the region of the filter bag 22 near the distal end 24 of the core wire engages with the distal end 18 of the basket 12, further pulling of the core wire 20 buckles the struts 14 to expand the basket 12, and hence the filter bag 22. Conversely, pushing the core wire 20 relative to the spiraled section 26 allows the basket 12 and the bag 22 to collapse to their pre-set state shown in FIG. 4 a, for example, for delivery or retrieval of the device 10. This feature allows a catheter to ride over the spiraled section 26 and the struts 14 for relatively easy collapse and retrieval of the device 10. As shown, four wires define the basket 12 and the spiraled section 26. However, depending on the application, as few as three or more than four struts may be employed.

When in its collapsed configuration (FIG. 4 a), the device 10 has a reduced diameter, so that its cross-sectional profile is less than the outer diameter of the device 10 in the expanded state. The struts 14 are generally straight and the bag 22 is distal to the distal end 18 of the basket 12. The filter bag 22 may include a set of radial spokes 33 embedded in the bag to prevent the bag from flopping around when it is disengaged from the basket 12. Moreover, the spokes 33 may be pre-set so that the filter bag 22 self-collapses about the core wire 20 when the bag 22 is disengaged from the basket 12.

The struts 14 may be formed from any suitable material such as a superelastic material, stainless steel wire, cobalt-chromium-nickel-molybdenum-iron alloy, or cobalt-chrome alloy. It is understood that in some implementations the struts 18 may be formed of any other suitable material that will result in a self-opening or self-expanding basket 14, such as shape memory alloys. Shape memory alloys have the desirable property of becoming rigid, that is, returning to a remembered state, when heated above a transition temperature. A shape memory alloy suitable for the present invention is Ni—Ti available under the more commonly known name Nitinol. When this material is heated above the transition temperature, the material undergoes a phase transformation from martensite to austenite, such that the material returns to its remembered state. The transition temperature is dependent on the relative proportions of the alloying elements Ni and Ti and the optional inclusion of alloying additives.

In one embodiment, the struts 14 are made from Nitinol with a transition temperature that is slightly below normal body temperature of humans (that is, about 98.6° F.). Thus, when the basket 12 is deployed in a body vessel and exposed to normal body temperature, the alloy of the struts 14 transform to austenite, such that the struts return to their remembered state, which for certain implementations is the expanded configuration when the basket 12 is deployed in the body vessel. To remove the basket 12, the basket is cooled to transform the alloy to martensite, which is more ductile than austenite, making the basket 12 more malleable, and hence more easily collapsible when, for example, a catheter is pushed over the basket 12.

In other embodiments, the basket 12 may be self-closing or self-collapsing. In such embodiments, the struts 14 may be made from Nitinol with a transition temperature that is above normal body temperature of humans. Thus, when the basket 12 is deployed in a body vessel and exposed to normal body temperature, the basket 12 is in the martensitic state so that the struts 14 are sufficiently ductile to form the basket 12 into an expanded configuration. To remove the basket 12, the basket is heated, for example, with a saline solution, to transform the alloy to austenite so that the basket 12 becomes rigid and returns to a remembered state, that is, a collapsed configuration.

The filter bag 22 may be formed from any suitable material to be used for capturing emboli from the stenotic lesion while allowing blood to flow through it. In a particular embodiment, the filter bag 22 is made of connective tissue material. The connective tissue may include extracellular matrix (ECM), which is a complex structural entity surrounding and supporting cells that are found within mammalian tissues. More specifically, ECM includes structural proteins (for example, collagen and elastin), specialized protein (for example, fibrillin, fibronectin, and laminin), and proteoglycans, a protein core to which are attached long chains of repeating disaccharide units termed glycosaminoglycans.

The extracellular matrix can be made of small intestinal submucosa (SIS). As known, SIS is a resorbable, acellular, naturally occurring tissue matrix composed of ECM proteins and various growth factors. SIS is derived from the porcine jejunum and functions as a remodeling bioscaffold for tissue repair. SIS has characteristics of an ideal tissue engineered biomaterial and can act as a bioscaffold for remodeling of many body tissues including skin, body wall, musculoskeletal structure, urinary bladder, and also supports new blood vessel growth. In many aspects, SIS is used to induce site-specific remodeling of both organs and tissues depending on the site of implantation. In theory, host cells are stimulated to proliferate and differentiate into site-specific connective tissue structures, which have been shown to completely replace the SIS material in time.

In some implementations, SIS is used to temporarily adhere the filter bag 22 to the walls of a body vessel in which the device 10 is deployed. SIS has a natural adherence or wettability to body fluids and connective cells that form the connective tissue of a body vessel wall. Because of the temporary nature of the duration in which the device 10 is deployed in the body vessel, host cells of the wall will adhere to the filter bag 16 but will not differentiate, allowing for retrieval of the device 10 from the body vessel.

In other embodiments, the filter bag 22 may be made of a mesh/net cloth, nylon, polymeric material, Teflon, or woven mixtures thereof.

In use, the device 10 expands from the collapsed state to the expanded state, engaging the basket 12 with the body vessel. In turn, the filter bag 22 expands to capture emboli during treatment of the stenotic lesion. After the device 10 is no longer needed, it may be retrieved.

The embolic protection device 10 may be used independently without any other delivery system or mechanism. Alternatively, the device 10 may be used, for example, with an embolic protection assembly 50 as depicted in FIGS. 5 a and 5 b.

As shown, the assembly 50 includes a balloon catheter 52 having a tubular body 54 and an expandable balloon 56 attached to and in fluid communication with the tubular body 54 for angioplasty at a stenotic lesion. The assembly 50 also includes the embolic protection device 10 described above. The tubular body 54 is preferably made of soft flexible material such as silicon or any other suitable material. The balloon catheter 52 may include an outer lumen that is in fluid communication with the balloon 56 for inflating and deflating the balloon 56 and an inner lumen formed within the outer lumen for percutaneous guidance through the body vessel with a wire a guide and for deploying the embolic protection device 10. In certain implementations, the balloon catheter 52 has a proximal fluid hub 72 in fluid communication with the balloon 56 by way of the outer lumen for fluid to be passed through the outer lumen for inflation and deflation of the balloon 56 during treatment of the stenotic lesion.

The assembly 50 further includes an inner catheter 62 with a distal end 64 through which the balloon catheter 52 is disposed for deployment in the body vessel. The inner catheter 62 is preferably made of a soft, flexible material such as silicon or any other suitable material. Generally, the inner catheter 62 also has a proximal end 58 and a plastic adaptor or hub 68 to receive the embolic protection device 10 and balloon catheter 52. The size of the inner catheter 62 is based on the size of the body vessel into which the catheter 62 is inserted, and the size of the balloon catheter 52.

The assembly 50 may also include a wire guide 70 configured to be percutaneously inserted within the vasculature to guide the inner catheter 62 to a location adjacent a stenotic lesion. Alternatively, the embolic protection device 10 may be employed as a wire guide.

To deploy the embolic protection device 10, the device 10 is placed in the inner lumen of the balloon catheter 52 prior to treatment of the stenotic lesion. The distal protection device is then guided through the inner lumen preferably from the hub 72 and distally beyond the balloon 56 of the balloon catheter 52, exiting from the distal end of the balloon catheter 52 to a location within the vasculature downstream of the stenotic lesion.

The assembly 50 may include a polytetrafluoroethylene (PTFE) introducer sheath 74 for percutaneously introducing the wire guide 70 and the inner catheter 62 in a body vessel. Of course, any other suitable material may be used. The introducer sheath 74 may have any suitable size, e.g., between about three-french to eight-french. The introducer serves to allow the inner and balloon catheters 62, 52 to be inserted percutaneously to a desired location in the body vessel. The introducer sheath 74 receives the inner catheter 62 and provides stability to the inner catheter at a desired location of the body vessel. For example, as the introducer sheath 74 is held stationary within a common visceral artery, it adds stability to the inner catheter 62, as the inner catheter 62 is advanced through the introducer sheath 74 to a dilatation area in the vasculature.

When the distal end 64 of the inner catheter 62 is at a location downstream of the dilatation area in the body vessel, the balloon catheter 52 is inserted through the inner catheter 62 to the dilatation area. The embolic protection device 10 is then loaded at the proximal end of the balloon catheter 52 and is advanced coaxially through the inner lumen of the balloon catheter 52 for deployment through the distal end of the balloon catheter. In this embodiment, the proximal end 28 of the core wire 24 can be used to mechanically advance or push the embolic protection device 10 through the catheter.

FIG. 6 depicts a sequence of steps of a process 100 for embolic protection during treatment of stenotic lesion in a body vessel when employing the assembly 50. The process 100 includes percutaneously introducing the balloon catheter 52 in a body vessel in a step 102, after the inner catheter 62 is disposed to a dilatation area within the body vessel. The physician may use any suitable means, for example, fluoroscopy, of verifying the placement of the balloon catheter at a dilatation area.

Next, in step 104, the embolic protection device 10 is placed in the collapsed state in the inner lumen of the balloon catheter 52 and advanced beyond the distal end of the balloon catheter, and, hence, beyond the dilatation area. The process 100 further includes deploying the device in an expanded state downstream from the stenotic lesion to capture emboli during treatment of the stenotic lesion in step 106. Optionally, the catheter may be withdrawn, and an alternative treatment device may be placed over the spiraled section 26 of the embolic protection device 10, that is, the device 10 may serve as a wire guide for the alternative treatment device.

In yet another example of the present invention, FIG. 7 depicts a process 200 for retrieving an embolic protection device for post-treatment of a stenotic lesion in a body vessel. In step 202, the process 200 includes sliding a catheter, such as the balloon catheter 52, over the spiraled section 26 of the embolic protection device 10 when the device is in a deployed state within the body vessel in step 202. Next, in step 204, the core wire 20 is pushed relative to the spiraled section 26 to collapse the basket 12, as well as the bag 22. The process 200 further includes, in step 206, retracting the embolic protection device 10 into the balloon catheter, and, in step 208, retrieving the catheter and the embolic protection device from the body vessel.

The above and other embodiments are within the scope of the following claims. 

1. A method for embolic protection during treatment of a stenotic lesion in a body vessel, the method comprising: disposing an embolic protection device in an undeployed state in the body vessel, the device comprising: a basket with a set of struts extending from a distal end to a proximal end of the basket, the struts being arranged to define an opening at the distal end, the basket having an expanded state and a collapsed state; a core wire with a distal end and a proximal end, the core wire being able to reciprocate through the opening at the distal end of the basket; and a filter bag attached only at the distal end of the core wire, the filter bag being located distally to the distal end of the basket when in the collapsed state; and moving the core wire relative to the basket to expand the basket and the filter bag in a deployed state downstream from the stenotic lesion to capture emboli during treatment of the stenotic lesion, the filter bag being disposed over substantially the entire basket when in their respective expanded states defining the deployed state.
 2. The method of claim 1 further comprising moving the core wire relative to the basket to close the basket and the filter bag to their respective collapsed states for retrieving the embolic protection device from the body vessel.
 3. The method of claim 1 wherein disposing the device in an undeployed state in the body vessel includes: introducing a catheter within the body vessel; and disposing the device within a lumen of the catheter, the basket and the filter bag being in their respective collapsed states, wherein the device is advanced beyond a distal end of the catheter to the deployed state.
 4. The method of claim 3 wherein the catheter is a balloon catheter.
 5. The method of claim 1 wherein the wherein the filter bag is made of a mesh material.
 6. The method of claim 1 wherein the filter bag is made of connective tissue including extracellular matrix.
 7. The method of claim 6 wherein the extracellular matrix is made of small intestinal submucosa.
 8. The method of claim 1 wherein the struts are made of shape memory material with a transition temperature.
 9. The method of claim 1 wherein the struts are made of superelastic material.
 10. The method of claim 9 wherein the superelastic material is Nitinol.
 11. The method of claim 5 wherein the filter bag includes a set of radial spokes to provide structural rigidity to the filter bag.
 12. The method of claim 11 wherein the radial spokes are pre-set such that the filter bag self-collapses to the collapsed state.
 13. A method for embolic protection during treatment of a stenotic lesion in a body vessel, the method comprising: introducing a balloon catheter within a body vessel; disposing an embolic protection device in a collapsed state within an inner lumen of the balloon catheter, the device comprising: a set of wires including a first section arranged as struts that define a basket with a distal end and a proximal end, the struts at the distal end of the basket being arranged to define an opening, the basket having a collapsed state and being configured to move to an expanded state; a core wire with a distal end and a proximal end, the core wire being able to reciprocate through the opening at the distal end of the basket; and a filter bag attached only at the distal end of the core wire, the filter bag having a collapsed state and being configured to move to an expanded state; advancing the device beyond a distal end of the balloon catheter; and deploying the device in an expanded state downstream from the stenotic lesion to capture emboli during treatment of the stenotic lesion, wherein deploying the device includes moving the core wire relative to the basket to expand the basket and the filter bag, the filter bag being disposed over substantially the entire basket when in the expanded state.
 14. The method of claim 13 further comprising moving the core wire relative to the basket to close the basket and the filter bag to their respective collapsed states for retrieving the embolic protection device from the body vessel.
 15. The method of claim 14 further comprising retracting the device into the lumen of the balloon catheter and retrieving the balloon catheter and the device from the body vessel.
 16. The method of claim 13 wherein the filter bag is located distally relative to the distal end of the basket when the filter bag and the basket are in their respective collapsed states, wherein movement of the core wire in the proximal direction relative to the basket causes the filter bag to be disposed over the basket, and wherein further movement of the core wire in the proximal direction causes the basket and the filter bag to open to the expanded state.
 17. The method of claim 16 wherein movement of the core wire in the distal direction relative to the basket causes the basket and the filter bag to close to their respective collapsed states.
 18. The method of claim 13 wherein the filter bag is made of a mesh material comprised of small intestinal submucosa.
 19. The method of claim 13 wherein the set of wires is made of Nitinol.
 20. The method of claim 13 wherein the filter bag includes a set of radial spokes to provide structural rigidity to the filter bag, wherein the radial spokes are pre-set such that the filter bag self-collapses to the collapsed state. 